Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
BMJ Case Rep ; 15(2)2022 Feb 07.
Article in English | MEDLINE | ID: mdl-35131788

ABSTRACT

Familial hypokalaemic periodic paralysis (FHPP) is a rare neuromuscular disorder that is classified under periodic paralysis (PP), which is characterised by episodes of muscle weakness. Common triggers include intense exercise, fasting or consumption of carbohydrate-rich meals. Hypokalaemic PP has an incidence of 1 in 100 000; despite the temporal association, cardiac manifestations are exceedingly rare. We present a case of FHPP, a channelopathy presenting with severe refractory hypokalaemia. The challenges with our patient were maintaining potassium levels within normal ranges and initiating a close follow-up plan. Due to the lack of clinical guidance in our case, many aspects of care, including surveillance, medications and genetic testing, remain unaddressed. Medical management includes aggressive correction with supplements, potassium-sparing diuretics and carbonic anhydrase inhibitors. Severe cases of dysrhythmias, especially ventricular fibrillation, require electrophysiology evaluation and possible implantation of a defibrillator to prevent sudden cardiac death.


Subject(s)
Hypokalemia , Hypokalemic Periodic Paralysis , Carbonic Anhydrase Inhibitors , Genetic Testing , Humans , Hypokalemia/etiology , Hypokalemic Periodic Paralysis/diagnosis , Hypokalemic Periodic Paralysis/drug therapy , Hypokalemic Periodic Paralysis/etiology , Paralysis , Potassium
SELECTION OF CITATIONS
SEARCH DETAIL
...